WhaleCreep

Tybourne Capital Management (HK) Ltd 13F holdings, Q1 2022

Hedge fundSEC filingsCompare with another fundHoldings as of 2022-03-31, filed 2022-05-04

Tybourne Capital Management (HK) Ltd disclosed 30 US equity positions worth $1.7bn in its Q1 2022 13F filing. Its largest position is MSFT at 8.0% of the reported book, followed by AMZN and ZNTL. Versus Q4 2021 it opened 8 new positions, added to 1, reduced 17 and exited 4.

$1.7bn
Reported equity book
Sum of the long US equity positions in the filing, at the values filed. Options are excluded.
30
Positions
Distinct securities in the equity book with a reported value above zero. Options are excluded.
8.0%
Largest position
The largest single position as a share of the reported equity book.
58.9%
Top 10 weight
The ten largest positions together, as a share of the reported equity book.
21
Effective positions
1 / HHI of portfolio weights: the number of equal-weight positions the book behaves like.
52
Quarters on file since Q4 2012
Quarters for which this manager's 13F holdings are on record.

Holdings

Against Q4 2021: 8 new, 1 added, 17 reduced, 4 exited

30 rows
MSFT MICROSOFT CORPTechnology8.0%$135m437,400–new
AMZN AMAZON COM INCConsumer Cyclical7.8%$131m40,300−55%reduced
ZNTL ZENTALIS PHARMACEUTICALS INCHealthcare6.6%$112m2.43m−7.7%reduced
V VISA INCFinancial Services6.3%$107m481,900−52%reduced
MELI MERCADOLIBREConsumer Cyclical6.3%$106m89,431−66%reduced
CANADIAN PAC RY LTD no ticker–5.6%$95.0m1.15m–new
XYZ BLOCK INCTechnology5.0%$84.9m625,900−31%reduced
SPGI S&P GLOBAL INCFinancial Services4.9%$82.1m200,100–new
SE SEA LTDConsumer Cyclical4.3%$73.0m609,730−48%reduced
LIN LINDE PLCBasic Materials4.1%$68.8m215,347–new
SHOP SHOPIFY INCTechnology3.8%$63.5m94,000−30%reduced
MDB MONGODB INCTechnology3.5%$58.6m132,000−65%reduced
TEAM ATLASSIAN CORP PLCTechnology3.3%$56.4m192,100+5.0%added
LRCX LAM RESEARCH CORPTechnology3.2%$54.3m101,000–new
TXN TEXAS INSTRS INCTechnology3.1%$53.1m289,200–new
QCOM QUALCOMM INCTechnology3.1%$53.0m346,800−4.6%reduced
BEKE KE HLDGS INCReal Estate3.0%$50.7m4.10m−75%reduced
BCYC BICYCLE THERAPEUTICS PLCHealthcare3.0%$50.6m1.15m−44%reduced
STNE STONECO LTDTechnology2.7%$45.1m3.86m−33%reduced
NVDA NVIDIA CORPORATIONTechnology2.6%$44.1m161,600–new
SNOW SNOWFLAKE INCTechnology2.5%$42.1m183,600−64%reduced
TWLO TWILIO INCTechnology2.3%$39.0m236,424−59%reduced
HTHT H WORLD GROUP LTDConsumer Cyclical1.6%$27.5m834,009−37%reduced
INBXUSD INHIBRX INC–1.0%$17.7m794,682−23%reduced
LIANY LIANBIO–0.7%$12.3m3.31m0.0%held
AMLX AMYLYX PHARMACEUTICALS INCHealthcare0.6%$9.9m768,603–new
EQRX INC no ticker–0.6%$9.4m2.29m0.0%held
TSHA TAYSHA GENE THERAPIES INCHealthcare0.2%$3.3m500,0000.0%held
RENEO PHARMACEUTICALS INC no ticker–0.1%$2.1m700,000−6.7%reduced
XCUR EXICURE INC–0.09%$1.5m7.33m0.0%held

Exited since Q4 2021

4 rows
PDD PDD HOLDINGS INC6.1%$204m
RBLX ROBLOX CORP2.9%$96.9m
GTLB GITLAB INC0.8%$27.3m
MELI KASZEK PIONEER CORP-A (MEKA US) no ticker0.2%$8.1m

Sector mix

  • Technology43.1%
  • Consumer Cyclical20.0%
  • Financial Services11.2%
  • Healthcare10.4%
  • Unclassified8.2%
  • Basic Materials4.1%
  • Real Estate3.0%

Book over time

Every quarter on file (52)
QuarterPositionsEquity book
Q3 20254$30.9m
Q2 20256$34.5m
Q1 20255$23.6m
Q4 202433$398m
Q3 202432$357m
Q2 202436$492m
Q1 202438$585m
Q4 202335$671m
Q3 202338$716m
Q2 202342$925m
Q1 202341$993m
Q4 202227$1.0bn
Q3 202226$1.0bn
Q2 202227$1.4bn
Q1 202230$1.7bn
Q4 202126$3.4bn
Q3 202124$4.0bn
Q2 202129$4.7bn
Q1 202132$4.6bn
Q4 202031$4.8bn
Q3 202029$4.1bn
Q2 202021$3.3bn
Q1 202021$2.7bn
Q4 201913$2.6bn
Q3 201912$2.3bn
Q2 201913$2.8bn
Q1 201911$2.6bn
Q4 20189$2.2bn
Q3 20189$2.3bn
Q2 20188$2.2bn
Q1 20188$2.0bn
Q4 20175$1.6bn
Q3 20176$1.3bn
Q2 20177$2.2bn
Q1 20179$2.2bn
Q4 201610$2.1bn
Q3 20169$2.0bn
Q2 201610$1.9bn
Q1 20169$1.5bn
Q4 20158$1.3bn
Q3 20158$1.4bn
Q2 20158$1.2bn
Q1 201510$1.1bn
Q4 201411$1.1bn
Q3 201411$1.0bn
Q2 201411$1.1bn
Q1 201413$878m
Q4 201312$915m
Q3 201311$754m
Q2 201310$427m
Q1 20137$262m
Q4 20128$239m

Where Tybourne Capital Management (HK) Ltd was early

31 rows
TRIP TRIPADVISOR INCQ1 20137 of 20313.6%13.6%8Exited by Q1 2015+42%
2663134D BITAUTO HLDGS LTDQ2 20132 of 670.09%1.3%2Exited by Q4 2013+47%
AMZN AMAZON.COM INC (AMZN US)Q2 20136 of 37813.2%22.4%47Exited by Q1 2025+1480%
ATHM AUTOHOME INCQ4 20131 of 1005.9%8.2%5Exited by Q1 2015−0.6%
MNST MONSTER BEVERAGE CORP NEWQ1 20142 of 13410.4%12.9%9Exited by Q3 2019+176%
NFLX NETFLIX INCQ2 201413 of 30110.0%20.6%17Exited by Q3 2020+623%
ONDK ON DECK CAP INCQ1 20152 of 705.9%5.9%7Exited by Q4 2016−73%
SAM BOSTON BEER INCQ1 20152 of 1254.3%9.1%8Exited by Q1 2017−36%
DNKN DUNKIN BRANDS GROUP INCQ1 20155 of 847.3%16.2%6Exited by Q3 2016−8.3%
CHTR CHARTER COMMUNICATIONS INC NQ2 20165 of 26927.7%27.7%4Exited by Q2 2017+43%
Z ZILLOW GROUP INC - C (Z US)Q2 201610 of 2303.1%7.8%6Exited by Q1 2025+104%
SNAP SNAP INCQ3 20179 of 24415.9%16.1%8Exited by Q4 2019+8.7%
TEAM ATLASSIAN CORP -CLASS A (TEAM US)Q2 20186 of 2248.6%13.9%20Exited by Q1 2025+289%
TAL TAL EDUCATION GROUPQ3 201811 of 11012.0%13.4%7Exited by Q2 2020+107%
FTCHQ FARFETCH LTD-CLASS A (FTCH US)Q1 20199 of 1730.2%7.6%10Exited by Q3 2023−78%
BCYC BICYCLE THERAPEUTICS LTD-ADR (BCYC US)Q2 20191 of 820.7%20.8%25Exited by Q3 2025−31%
UBER UBER TECHNOLOGIES INCQ2 201914 of 3664.9%4.9%2Exited by Q4 2019−34%
CHWY CHEWY INC - CLASS A (CHWY US)Q1 20207 of 1884.8%4.8%5Exited by Q2 2021+126%
ZNTL ZENTALIS PHARMACEUTICALS INC (ZNTL US)Q2 20202 of 873.9%6.6%22Held at last filing, Q3 2025−97%
MTCH MATCH GROUP INC (MTCH US)Q2 202019 of 2398.3%8.3%4Exited by Q2 2021+28%
NCNO NCINO INCQ3 20202 of 1530.8%1.5%2Exited by Q1 2021−9.1%
TSHA TAYSHA GENE THERAPIES INC (TSHA US)Q3 20206 of 1030.3%39.1%21Held at last filing, Q3 2025−85%
DKNG DRAFTKINGS INC - CL A (DKNG US)Q3 20208 of 2201.8%3.0%3Exited by Q2 2021+4.2%
BEKE KE HOLDINGS INC-ADR (BEKE US)Q4 202010 of 1394.2%9.6%15Exited by Q3 2024−77%
BILL BILL.COM HOLDINGS INC (BILL US)Q4 202011 of 2453.7%3.7%3Exited by Q3 2021+34%
MDB MONGODB INC (MDB US)Q4 202019 of 2286.0%6.9%13Exited by Q1 2024+14%
SNOW SNOWFLAKE INC-CLASS A (SNOW US)Q4 202031 of 3021.2%7.3%8Exited by Q2 2023−45%
AMLX AMYLYX PHARMACEUTICALS INC (AMLX US)Q1 20224 of 1050.6%1.1%2Exited by Q3 2022+50%
SLRN ACELYRIN INC (SLRN US)Q2 20231 of 665.0%30.5%8Exited by Q2 2025−88%
CP CANADIAN PACIFIC KANSAS CITY (CP US)Q2 20235 of 1498.7%13.7%7Exited by Q1 2025−10%
ALMS ALUMIS INC (ALMS US)Q2 20253 of 7912.2%18.0%2Held at last filing, Q3 2025+33%

Concentration and tenure

14.1%
Median largest position, all quarters
The largest single position as a share of the reported equity book.
97.9%
Median top 10 weight, all quarters
The ten largest positions together, as a share of the reported equity book.
Concentrated
Style, by median largest position
2
Median completed holding, quarters